Effects of Sitagliptin Treatment on Dysmetabolism, Inflammation, and Oxidative Stress in an Animal Model of Type 2 Diabetes (ZDF Rat)
Figure 2
Serum inflammatory markers. Serum CRPhs (a), IL-1 (b), TNF- (c) and Adiponectin (d) for the control () and diabetic (fa/fa) ZDF rats, in the initial and final times (6 weeks of vehicle or 10 mg/kg BW/day sitagliptin treatment). Comparisons between groups ( each): a - ZDF (fa/fa) versus ZDF () and b - with sita versus without sita; and for one, two or three letters, respectively. CRPhs, high-sensitive C-reactive protein; IL-1, interleukin-1beta; TNF-, Tumor necrosis factor-alpha.